Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 5.69538403 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.69538403 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.40223420 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.40223420 |
5 | indole-containing compound catabolic process (GO:0042436) | 5.39729560 |
6 | indolalkylamine catabolic process (GO:0046218) | 5.39729560 |
7 | tryptophan catabolic process (GO:0006569) | 5.39729560 |
8 | L-phenylalanine metabolic process (GO:0006558) | 5.27837447 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.27837447 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 5.24276316 |
11 | valine metabolic process (GO:0006573) | 5.16167019 |
12 | negative thymic T cell selection (GO:0045060) | 5.10113776 |
13 | kynurenine metabolic process (GO:0070189) | 5.03053797 |
14 | tryptophan metabolic process (GO:0006568) | 5.01676114 |
15 | negative T cell selection (GO:0043383) | 4.98773529 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94608460 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.90691522 |
18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78081193 |
19 | response to interleukin-15 (GO:0070672) | 4.78023377 |
20 | glyoxylate metabolic process (GO:0046487) | 4.75228638 |
21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.74983313 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68340565 |
23 | amino-acid betaine metabolic process (GO:0006577) | 4.61359953 |
24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.43277361 |
25 | protein carboxylation (GO:0018214) | 4.33711973 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.33711973 |
27 | positive thymic T cell selection (GO:0045059) | 4.29641253 |
28 | histone H3-K36 demethylation (GO:0070544) | 4.29376874 |
29 | activated T cell proliferation (GO:0050798) | 4.27305781 |
30 | alpha-linolenic acid metabolic process (GO:0036109) | 4.24918004 |
31 | bile acid biosynthetic process (GO:0006699) | 4.23185858 |
32 | phospholipid efflux (GO:0033700) | 4.22856120 |
33 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.18947991 |
34 | positive regulation of granulocyte differentiation (GO:0030854) | 4.18094593 |
35 | lysine metabolic process (GO:0006553) | 4.16696757 |
36 | lysine catabolic process (GO:0006554) | 4.16696757 |
37 | positive T cell selection (GO:0043368) | 4.15877789 |
38 | urea cycle (GO:0000050) | 4.15050189 |
39 | urea metabolic process (GO:0019627) | 4.15050189 |
40 | thymic T cell selection (GO:0045061) | 4.13720383 |
41 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.07657527 |
42 | cellular response to interleukin-15 (GO:0071350) | 4.05703310 |
43 | B cell receptor signaling pathway (GO:0050853) | 4.00041625 |
44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98647341 |
45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.97574572 |
46 | alpha-amino acid catabolic process (GO:1901606) | 3.94339312 |
47 | 2-oxoglutarate metabolic process (GO:0006103) | 3.94067373 |
48 | tricarboxylic acid metabolic process (GO:0072350) | 3.91106834 |
49 | T cell selection (GO:0045058) | 3.90936580 |
50 | carnitine metabolic process (GO:0009437) | 3.87562808 |
51 | tolerance induction (GO:0002507) | 3.85247376 |
52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.78017961 |
53 | aromatic amino acid family metabolic process (GO:0009072) | 3.77111777 |
54 | nitrogen cycle metabolic process (GO:0071941) | 3.76162811 |
55 | cysteine metabolic process (GO:0006534) | 3.75248739 |
56 | glycine metabolic process (GO:0006544) | 3.73685848 |
57 | histone H4 deacetylation (GO:0070933) | 3.71696262 |
58 | plasma lipoprotein particle assembly (GO:0034377) | 3.71264094 |
59 | serine family amino acid catabolic process (GO:0009071) | 3.70778919 |
60 | sulfur amino acid catabolic process (GO:0000098) | 3.68677887 |
61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.66051930 |
62 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.65150981 |
63 | cellular amino acid catabolic process (GO:0009063) | 3.57591784 |
64 | interferon-gamma production (GO:0032609) | 3.53935606 |
65 | indolalkylamine metabolic process (GO:0006586) | 3.53365840 |
66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52508704 |
67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52508704 |
68 | bile acid metabolic process (GO:0008206) | 3.49689326 |
69 | oxaloacetate metabolic process (GO:0006107) | 3.48557587 |
70 | cellular modified amino acid catabolic process (GO:0042219) | 3.42446944 |
71 | aspartate family amino acid catabolic process (GO:0009068) | 3.40419591 |
72 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39254164 |
73 | modulation by symbiont of host defense response (GO:0052031) | 3.39254164 |
74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39254164 |
75 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39254164 |
76 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39254164 |
77 | modulation by symbiont of host immune response (GO:0052553) | 3.39254164 |
78 | glutamate metabolic process (GO:0006536) | 3.37462838 |
79 | serine family amino acid biosynthetic process (GO:0009070) | 3.36707386 |
80 | mannose metabolic process (GO:0006013) | 3.36420160 |
81 | serine family amino acid metabolic process (GO:0009069) | 3.35599426 |
82 | cellular biogenic amine catabolic process (GO:0042402) | 3.34650773 |
83 | amine catabolic process (GO:0009310) | 3.34650773 |
84 | fructose metabolic process (GO:0006000) | 3.34392567 |
85 | regulation of cholesterol homeostasis (GO:2000188) | 3.34122382 |
86 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34098493 |
87 | histone H3 deacetylation (GO:0070932) | 3.32525153 |
88 | protein-lipid complex assembly (GO:0065005) | 3.31442011 |
89 | negative regulation of cholesterol transport (GO:0032375) | 3.29315450 |
90 | negative regulation of sterol transport (GO:0032372) | 3.29315450 |
91 | branched-chain amino acid metabolic process (GO:0009081) | 3.28687288 |
92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.28604687 |
93 | branched-chain amino acid catabolic process (GO:0009083) | 3.28601084 |
94 | regulation of protein activation cascade (GO:2000257) | 3.27986782 |
95 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.27417833 |
96 | histone H3-K9 modification (GO:0061647) | 3.26951415 |
97 | NAD biosynthetic process (GO:0009435) | 3.26835190 |
98 | pentose-phosphate shunt (GO:0006098) | 3.26393025 |
99 | complement activation, alternative pathway (GO:0006957) | 3.25911039 |
100 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.25730072 |
101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.25730072 |
102 | histone H3-K9 demethylation (GO:0033169) | 3.24835514 |
103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.24277337 |
104 | negative regulation of fibrinolysis (GO:0051918) | 3.24247508 |
105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.23788881 |
106 | benzene-containing compound metabolic process (GO:0042537) | 3.23728505 |
107 | fatty acid beta-oxidation (GO:0006635) | 3.23536959 |
108 | regulation of ARF protein signal transduction (GO:0032012) | 3.22447150 |
109 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.22052616 |
110 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.22052616 |
111 | histone H3-K4 trimethylation (GO:0080182) | 3.21974114 |
112 | coenzyme catabolic process (GO:0009109) | 3.21562235 |
113 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.21100459 |
114 | phospholipid homeostasis (GO:0055091) | 3.20047059 |
115 | imidazole-containing compound metabolic process (GO:0052803) | 3.19503612 |
116 | carboxylic acid catabolic process (GO:0046395) | 3.19078559 |
117 | organic acid catabolic process (GO:0016054) | 3.19078559 |
118 | plasma lipoprotein particle remodeling (GO:0034369) | 3.18862737 |
119 | protein-lipid complex remodeling (GO:0034368) | 3.18862737 |
120 | macromolecular complex remodeling (GO:0034367) | 3.18862737 |
121 | homocysteine metabolic process (GO:0050667) | 3.18012308 |
122 | NAD metabolic process (GO:0019674) | 3.17590224 |
123 | fatty acid oxidation (GO:0019395) | 3.17360560 |
124 | detection of bacterium (GO:0016045) | 3.15529560 |
125 | negative regulation of B cell mediated immunity (GO:0002713) | 3.15084806 |
126 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.15084806 |
127 | ethanol oxidation (GO:0006069) | 3.13871826 |
128 | regulation of B cell differentiation (GO:0045577) | 3.12949981 |
129 | urate metabolic process (GO:0046415) | 3.12821088 |
130 | negative regulation of bone resorption (GO:0045779) | 3.12747083 |
131 | carnitine shuttle (GO:0006853) | 3.12043285 |
132 | lipid oxidation (GO:0034440) | 3.11733982 |
133 | reverse cholesterol transport (GO:0043691) | 3.11316887 |
134 | regulation of triglyceride catabolic process (GO:0010896) | 3.09445351 |
135 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.09422965 |
136 | cholesterol efflux (GO:0033344) | 3.09208238 |
137 | fatty acid transmembrane transport (GO:1902001) | 3.08665489 |
138 | regulation of fibrinolysis (GO:0051917) | 3.08170246 |
139 | acylglycerol homeostasis (GO:0055090) | 3.07253137 |
140 | triglyceride homeostasis (GO:0070328) | 3.07253137 |
141 | tyrosine metabolic process (GO:0006570) | 3.06982040 |
142 | fatty acid catabolic process (GO:0009062) | 3.06843044 |
143 | leukocyte aggregation (GO:0070486) | 3.04231244 |
144 | positive regulation of tolerance induction (GO:0002645) | 3.03641034 |
145 | regulation of complement activation (GO:0030449) | 3.02507636 |
146 | monocarboxylic acid catabolic process (GO:0072329) | 3.01979415 |
147 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.00290630 |
148 | mast cell activation (GO:0045576) | 2.99168314 |
149 | nucleotide salvage (GO:0043173) | 2.98540764 |
150 | drug catabolic process (GO:0042737) | 2.97521180 |
151 | positive regulation of respiratory burst (GO:0060267) | 2.97121603 |
152 | regulation of histone H3-K27 methylation (GO:0061085) | 2.95784723 |
153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95733718 |
154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95181504 |
155 | drug transmembrane transport (GO:0006855) | 2.93499153 |
156 | dicarboxylic acid metabolic process (GO:0043648) | 2.92526896 |
157 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90749193 |
158 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87223891 |
159 | regulation of granulocyte differentiation (GO:0030852) | 2.86180185 |
160 | histone lysine demethylation (GO:0070076) | 2.84766036 |
161 | response to muramyl dipeptide (GO:0032495) | 2.83565867 |
162 | detection of other organism (GO:0098543) | 2.82529931 |
163 | regulation of tolerance induction (GO:0002643) | 2.81006999 |
164 | positive regulation of B cell differentiation (GO:0045579) | 2.80747298 |
165 | regulation of T cell tolerance induction (GO:0002664) | 2.80746113 |
166 | histone demethylation (GO:0016577) | 2.79930465 |
167 | histone H3-K9 methylation (GO:0051567) | 2.77718937 |
168 | T cell receptor signaling pathway (GO:0050852) | 2.76040149 |
169 | negative regulation of adaptive immune response (GO:0002820) | 2.75231393 |
170 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.74584514 |
171 | Peyers patch development (GO:0048541) | 2.74584514 |
172 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67937988 |
173 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67092181 |
174 | T cell migration (GO:0072678) | 2.65172773 |
175 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64554838 |
176 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64554838 |
177 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64100815 |
178 | positive regulation of Rap GTPase activity (GO:0032854) | 2.63161925 |
179 | mast cell degranulation (GO:0043303) | 2.61828716 |
180 | mast cell activation involved in immune response (GO:0002279) | 2.61828716 |
181 | immunoglobulin mediated immune response (GO:0016064) | 2.61680262 |
182 | negative regulation of innate immune response (GO:0045824) | 2.60156471 |
183 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60108573 |
184 | axonemal dynein complex assembly (GO:0070286) | 2.59968338 |
185 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.58575033 |
186 | natural killer cell differentiation (GO:0001779) | 2.57319253 |
187 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57024369 |
188 | positive regulation of histone deacetylation (GO:0031065) | 2.55317791 |
189 | modulation by virus of host process (GO:0019054) | 2.51474602 |
190 | protein demethylation (GO:0006482) | 2.50933928 |
191 | protein dealkylation (GO:0008214) | 2.50933928 |
192 | macroautophagy (GO:0016236) | 2.49777642 |
193 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.49437344 |
194 | regulation of beta-amyloid formation (GO:1902003) | 2.49234226 |
195 | energy homeostasis (GO:0097009) | 2.48644722 |
196 | lung epithelium development (GO:0060428) | 2.47886077 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.71464009 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52664244 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.44208227 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.27945400 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.60935242 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.31389021 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20309648 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.95533289 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.94219445 |
10 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.68506085 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.67154602 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65811319 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.51926448 |
14 | MYC_22102868_ChIP-Seq_BL_Human | 2.48531260 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.33559042 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25600865 |
17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24046454 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20627163 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19128867 |
20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13010196 |
21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.10663760 |
22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97853083 |
23 | MYB_26560356_Chip-Seq_TH2_Human | 1.96433318 |
24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93349697 |
25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90195709 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86119207 |
27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83488011 |
28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75823249 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74818752 |
30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70089290 |
31 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.69091555 |
32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69068675 |
33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68538009 |
34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.68445280 |
35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67691802 |
36 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66923253 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64287820 |
38 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60408463 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59484055 |
40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58202232 |
41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54475453 |
42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.50777104 |
43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50625260 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49024954 |
45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46825234 |
46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43367274 |
47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43331988 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.43313791 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43073093 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40524579 |
51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38289062 |
52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37683547 |
53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37098803 |
54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35476613 |
55 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33839826 |
56 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.33676606 |
57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33521153 |
58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32874948 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31874787 |
60 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.31674134 |
61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31023301 |
62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30957339 |
63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29260326 |
64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28218459 |
65 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27357280 |
66 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26871268 |
67 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26382451 |
68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.26006203 |
69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24262942 |
70 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.23718381 |
71 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.23460401 |
72 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20403791 |
73 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19551837 |
74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18989846 |
75 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.18839450 |
76 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18752824 |
77 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.18382961 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17296973 |
79 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17127791 |
80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16026980 |
81 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15670602 |
82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15438298 |
83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14452790 |
84 | MYB_26560356_Chip-Seq_TH1_Human | 1.14135512 |
85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13290220 |
86 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.13120623 |
87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12247302 |
88 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12237252 |
89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12099738 |
90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10563835 |
91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10103904 |
92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09585008 |
93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07621072 |
94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07121903 |
95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.06882500 |
96 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06813858 |
97 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06316735 |
98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06099404 |
99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05834701 |
100 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05070660 |
101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04993567 |
102 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.04907740 |
103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04672690 |
104 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.04329785 |
105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03987841 |
106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02967556 |
107 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02828346 |
108 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02765157 |
109 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02360468 |
110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02200700 |
111 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01718604 |
112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01618901 |
113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01105589 |
114 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01059609 |
115 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00675162 |
116 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00591236 |
117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00477713 |
118 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99897834 |
119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99038329 |
120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98713409 |
121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97716340 |
122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97291154 |
123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96984945 |
124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96174385 |
125 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96035116 |
126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95829570 |
127 | P68_20966046_ChIP-Seq_HELA_Human | 0.95676853 |
128 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95658989 |
129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95520392 |
130 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95312949 |
131 | MAF_26560356_Chip-Seq_TH2_Human | 0.95216485 |
132 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93203678 |
133 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92588834 |
134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91693239 |
135 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91650958 |
136 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.89750894 |
137 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89199989 |
138 | P300_27268052_Chip-Seq_Bcells_Human | 0.88448391 |
139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86411360 |
140 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85919013 |
141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84974420 |
142 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84560219 |
143 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84432446 |
144 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83168711 |
145 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83046043 |
146 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82272350 |
147 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82256102 |
148 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81379605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.87040637 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.99956001 |
3 | MP0005365_abnormal_bile_salt | 4.88834212 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.28570578 |
5 | MP0010329_abnormal_lipoprotein_level | 3.32038008 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09544701 |
7 | MP0003787_abnormal_imprinting | 3.04502442 |
8 | MP0003763_abnormal_thymus_physiology | 2.97885338 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.95616357 |
10 | MP0003252_abnormal_bile_duct | 2.68802853 |
11 | MP0003122_maternal_imprinting | 2.60185262 |
12 | MP0009840_abnormal_foam_cell | 2.47120512 |
13 | MP0001986_abnormal_taste_sensitivity | 2.38381875 |
14 | MP0001790_abnormal_immune_system | 2.37742761 |
15 | MP0005387_immune_system_phenotype | 2.37742761 |
16 | MP0005332_abnormal_amino_acid | 2.34222991 |
17 | MP0002653_abnormal_ependyma_morphology | 2.28779659 |
18 | MP0008995_early_reproductive_senescence | 2.21760879 |
19 | MP0003191_abnormal_cellular_cholesterol | 2.15207884 |
20 | MP0001666_abnormal_nutrient_absorption | 2.11828326 |
21 | MP0001764_abnormal_homeostasis | 2.10899029 |
22 | MP0004381_abnormal_hair_follicle | 2.06592583 |
23 | MP0005000_abnormal_immune_tolerance | 1.98503408 |
24 | MP0002132_abnormal_respiratory_system | 1.98074808 |
25 | MP0000609_abnormal_liver_physiology | 1.97385329 |
26 | MP0006036_abnormal_mitochondrial_physio | 1.95755180 |
27 | MP0002118_abnormal_lipid_homeostasis | 1.93031612 |
28 | MP0005377_hearing/vestibular/ear_phenot | 1.87746120 |
29 | MP0003878_abnormal_ear_physiology | 1.87746120 |
30 | MP0003724_increased_susceptibility_to | 1.82907597 |
31 | MP0004019_abnormal_vitamin_homeostasis | 1.76313348 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.73039793 |
33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72783942 |
34 | MP0003172_abnormal_lysosome_physiology | 1.72665008 |
35 | MP0000703_abnormal_thymus_morphology | 1.70220877 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.63834552 |
37 | MP0004145_abnormal_muscle_electrophysio | 1.62830428 |
38 | MP0008260_abnormal_autophagy | 1.62301015 |
39 | MP0005645_abnormal_hypothalamus_physiol | 1.60866101 |
40 | MP0005464_abnormal_platelet_physiology | 1.60129225 |
41 | MP0005083_abnormal_biliary_tract | 1.55725332 |
42 | MP0004084_abnormal_cardiac_muscle | 1.54540943 |
43 | MP0002405_respiratory_system_inflammati | 1.50773076 |
44 | MP0003866_abnormal_defecation | 1.47353837 |
45 | MP0004130_abnormal_muscle_cell | 1.46886912 |
46 | MP0004043_abnormal_pH_regulation | 1.45890928 |
47 | MP0003123_paternal_imprinting | 1.45175356 |
48 | MP0009697_abnormal_copulation | 1.44921527 |
49 | MP0003303_peritoneal_inflammation | 1.42738299 |
50 | MP0005310_abnormal_salivary_gland | 1.40296121 |
51 | MP0001661_extended_life_span | 1.38185531 |
52 | MP0003121_genomic_imprinting | 1.36122900 |
53 | MP0009643_abnormal_urine_homeostasis | 1.36060541 |
54 | MP0001835_abnormal_antigen_presentation | 1.35655683 |
55 | MP0002254_reproductive_system_inflammat | 1.34373922 |
56 | MP0005423_abnormal_somatic_nervous | 1.34233243 |
57 | MP0001873_stomach_inflammation | 1.32487961 |
58 | MP0002396_abnormal_hematopoietic_system | 1.29853407 |
59 | MP0004036_abnormal_muscle_relaxation | 1.29704893 |
60 | MP0005551_abnormal_eye_electrophysiolog | 1.29154764 |
61 | MP0008877_abnormal_DNA_methylation | 1.28910160 |
62 | MP0008961_abnormal_basal_metabolism | 1.27218737 |
63 | MP0002933_joint_inflammation | 1.23914995 |
64 | MP0001800_abnormal_humoral_immune | 1.23884841 |
65 | MP0005670_abnormal_white_adipose | 1.23703941 |
66 | MP0000598_abnormal_liver_morphology | 1.21737695 |
67 | MP0001502_abnormal_circadian_rhythm | 1.20713636 |
68 | MP0004147_increased_porphyrin_level | 1.17901339 |
69 | MP0000685_abnormal_immune_system | 1.17512634 |
70 | MP0006035_abnormal_mitochondrial_morpho | 1.16514149 |
71 | MP0001968_abnormal_touch/_nociception | 1.12375740 |
72 | MP0009785_altered_susceptibility_to | 1.12283409 |
73 | MP0006054_spinal_hemorrhage | 1.10954743 |
74 | MP0000689_abnormal_spleen_morphology | 1.10621042 |
75 | MP0008469_abnormal_protein_level | 1.08599312 |
76 | MP0004264_abnormal_extraembryonic_tissu | 1.08043180 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 1.07060770 |
78 | MP0002166_altered_tumor_susceptibility | 1.04956373 |
79 | MP0002928_abnormal_bile_duct | 1.04017232 |
80 | MP0005671_abnormal_response_to | 1.03390692 |
81 | MP0002971_abnormal_brown_adipose | 1.03044888 |
82 | MP0005174_abnormal_tail_pigmentation | 1.02967294 |
83 | MP0009672_abnormal_birth_weight | 1.02004476 |
84 | MP0003436_decreased_susceptibility_to | 1.01535058 |
85 | MP0005266_abnormal_metabolism | 1.00213674 |
86 | MP0009642_abnormal_blood_homeostasis | 0.99454371 |
87 | MP0001984_abnormal_olfaction | 0.99444658 |
88 | MP0001348_abnormal_lacrimal_gland | 0.98466115 |
89 | MP0000569_abnormal_digit_pigmentation | 0.95438243 |
90 | MP0002136_abnormal_kidney_physiology | 0.94846661 |
91 | MP0002722_abnormal_immune_system | 0.92442657 |
92 | MP0005451_abnormal_body_composition | 0.92346053 |
93 | MP0002398_abnormal_bone_marrow | 0.90602070 |
94 | MP0004742_abnormal_vestibular_system | 0.90096376 |
95 | MP0005058_abnormal_lysosome_morphology | 0.88673701 |
96 | MP0003868_abnormal_feces_composition | 0.88356273 |
97 | MP0002452_abnormal_antigen_presenting | 0.87521682 |
98 | MP0004808_abnormal_hematopoietic_stem | 0.87322577 |
99 | MP0009763_increased_sensitivity_to | 0.87274599 |
100 | MP0002138_abnormal_hepatobiliary_system | 0.86738077 |
101 | MP0003329_amyloid_beta_deposits | 0.86196852 |
102 | MP0002723_abnormal_immune_serum | 0.85998126 |
103 | MP0003011_delayed_dark_adaptation | 0.85931323 |
104 | MP0002009_preneoplasia | 0.85581030 |
105 | MP0005376_homeostasis/metabolism_phenot | 0.85354140 |
106 | MP0010155_abnormal_intestine_physiology | 0.84176060 |
107 | MP0000716_abnormal_immune_system | 0.83668198 |
108 | MP0003566_abnormal_cell_adhesion | 0.83029673 |
109 | MP0008775_abnormal_heart_ventricle | 0.83027111 |
110 | MP0001765_abnormal_ion_homeostasis | 0.82428816 |
111 | MP0005636_abnormal_mineral_homeostasis | 0.82299647 |
112 | MP0002429_abnormal_blood_cell | 0.82220286 |
113 | MP0002419_abnormal_innate_immunity | 0.81906274 |
114 | MP0002089_abnormal_postnatal_growth/wei | 0.81374478 |
115 | MP0008569_lethality_at_weaning | 0.81033568 |
116 | MP0002420_abnormal_adaptive_immunity | 0.80349542 |
117 | MP0009764_decreased_sensitivity_to | 0.79000170 |
118 | MP0001533_abnormal_skeleton_physiology | 0.78498663 |
119 | MP0002078_abnormal_glucose_homeostasis | 0.77980672 |
120 | MP0001819_abnormal_immune_cell | 0.77348659 |
121 | MP0002557_abnormal_social/conspecific_i | 0.77030090 |
122 | MP0002970_abnormal_white_adipose | 0.76768336 |
123 | MP0004947_skin_inflammation | 0.75448019 |
124 | MP0001663_abnormal_digestive_system | 0.73525269 |
125 | MP0003183_abnormal_peptide_metabolism | 0.73007541 |
126 | MP0003943_abnormal_hepatobiliary_system | 0.72969586 |
127 | MP0005025_abnormal_response_to | 0.72968814 |
128 | MP0001845_abnormal_inflammatory_respons | 0.72677926 |
129 | MP0003195_calcinosis | 0.72507346 |
130 | MP0005535_abnormal_body_temperature | 0.72477837 |
131 | MP0005075_abnormal_melanosome_morpholog | 0.71811335 |
132 | MP0008874_decreased_physiological_sensi | 0.71020902 |
133 | MP0001324_abnormal_eye_pigmentation | 0.70260967 |
134 | MP0000749_muscle_degeneration | 0.70157434 |
135 | MP0003705_abnormal_hypodermis_morpholog | 0.69980184 |
136 | MP0010307_abnormal_tumor_latency | 0.69627195 |
137 | MP0005330_cardiomyopathy | 0.69407588 |
138 | MP0005666_abnormal_adipose_tissue | 0.69208258 |
139 | MP0002693_abnormal_pancreas_physiology | 0.69089791 |
140 | MP0008872_abnormal_physiological_respon | 0.68764038 |
141 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67580669 |
142 | MP0000566_synostosis | 0.67059439 |
143 | MP0000230_abnormal_systemic_arterial | 0.66313720 |
144 | MP0000604_amyloidosis | 0.65615081 |
145 | MP0002277_abnormal_respiratory_mucosa | 0.65563065 |
146 | MP0005499_abnormal_olfactory_system | 0.64274368 |
147 | MP0005394_taste/olfaction_phenotype | 0.64274368 |
148 | MP0009115_abnormal_fat_cell | 0.63995446 |
149 | MP0010630_abnormal_cardiac_muscle | 0.63779739 |
150 | MP0001756_abnormal_urination | 0.63468414 |
151 | MP0001851_eye_inflammation | 0.63172009 |
152 | MP0004133_heterotaxia | 0.62639767 |
153 | MP0002063_abnormal_learning/memory/cond | 0.61537769 |
154 | MP0003880_abnormal_central_pattern | 0.60152808 |
155 | MP0002064_seizures | 0.57417871 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperlipoproteinemia (HP:0010980) | 4.86739800 |
2 | Prolonged partial thromboplastin time (HP:0003645) | 4.65880839 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.31069456 |
4 | Xanthomatosis (HP:0000991) | 4.16072095 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.09163362 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.05206627 |
7 | Ketosis (HP:0001946) | 4.01621974 |
8 | Deep venous thrombosis (HP:0002625) | 3.95013685 |
9 | Congenital stationary night blindness (HP:0007642) | 3.73350681 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.72582020 |
11 | Eczematoid dermatitis (HP:0000976) | 3.69960358 |
12 | Joint hemorrhage (HP:0005261) | 3.69433447 |
13 | Hypobetalipoproteinemia (HP:0003563) | 3.65889609 |
14 | Myositis (HP:0100614) | 3.48539338 |
15 | Pustule (HP:0200039) | 3.47861528 |
16 | Hyperammonemia (HP:0001987) | 3.39116776 |
17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36162086 |
18 | Recurrent fungal infections (HP:0002841) | 3.25597395 |
19 | Panhypogammaglobulinemia (HP:0003139) | 3.25145108 |
20 | Gastrointestinal infarctions (HP:0005244) | 3.20872657 |
21 | Hyperglycinuria (HP:0003108) | 3.20824881 |
22 | Papilledema (HP:0001085) | 3.20525669 |
23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20312196 |
24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20249563 |
25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.17895226 |
26 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.17895226 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16036516 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16036516 |
29 | Absent/shortened dynein arms (HP:0200106) | 3.09868886 |
30 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.09868886 |
31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.08260213 |
32 | Ragged-red muscle fibers (HP:0003200) | 3.02620017 |
33 | Encephalitis (HP:0002383) | 3.01747313 |
34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00946520 |
35 | Abnormality of glycine metabolism (HP:0010895) | 3.00946520 |
36 | Hypercholesterolemia (HP:0003124) | 2.99096565 |
37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.98298457 |
38 | Retrobulbar optic neuritis (HP:0100654) | 2.98045063 |
39 | Optic neuritis (HP:0100653) | 2.98045063 |
40 | Agammaglobulinemia (HP:0004432) | 2.96793824 |
41 | Asplenia (HP:0001746) | 2.92911468 |
42 | Hyperbilirubinemia (HP:0002904) | 2.92763563 |
43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.92149389 |
44 | Gout (HP:0001997) | 2.87809279 |
45 | Meningitis (HP:0001287) | 2.87233017 |
46 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.86786270 |
47 | Ketoacidosis (HP:0001993) | 2.85657498 |
48 | Orchitis (HP:0100796) | 2.84557029 |
49 | Recurrent bacterial skin infections (HP:0005406) | 2.81926620 |
50 | Hypoglycemic coma (HP:0001325) | 2.80830207 |
51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79769188 |
52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.79625267 |
53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.77521304 |
54 | Lymphopenia (HP:0001888) | 2.74599081 |
55 | Delayed CNS myelination (HP:0002188) | 2.74490977 |
56 | Hyperglycinemia (HP:0002154) | 2.73737557 |
57 | Increased IgE level (HP:0003212) | 2.71599783 |
58 | Abnormal gallbladder physiology (HP:0012438) | 2.71090184 |
59 | Cholecystitis (HP:0001082) | 2.71090184 |
60 | Chronic otitis media (HP:0000389) | 2.69558485 |
61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68084390 |
62 | Hypolipoproteinemia (HP:0010981) | 2.67967547 |
63 | Complement deficiency (HP:0004431) | 2.67334330 |
64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67275776 |
65 | Vasculitis (HP:0002633) | 2.66463817 |
66 | Abnormality of methionine metabolism (HP:0010901) | 2.65418582 |
67 | Hepatocellular carcinoma (HP:0001402) | 2.64472248 |
68 | Colitis (HP:0002583) | 2.63592156 |
69 | Bronchiectasis (HP:0002110) | 2.63077366 |
70 | Abnormality of T cells (HP:0002843) | 2.62790763 |
71 | Recurrent abscess formation (HP:0002722) | 2.55850776 |
72 | Myoglobinuria (HP:0002913) | 2.54456685 |
73 | Hypochromic anemia (HP:0001931) | 2.54369712 |
74 | Prolonged bleeding time (HP:0003010) | 2.54127212 |
75 | Severe combined immunodeficiency (HP:0004430) | 2.52406382 |
76 | Recurrent skin infections (HP:0001581) | 2.51565053 |
77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.48043233 |
78 | Epistaxis (HP:0000421) | 2.45719123 |
79 | Mediastinal lymphadenopathy (HP:0100721) | 2.44296616 |
80 | Late onset (HP:0003584) | 2.44293252 |
81 | Fat malabsorption (HP:0002630) | 2.43088972 |
82 | T lymphocytopenia (HP:0005403) | 2.42371491 |
83 | Reticulocytosis (HP:0001923) | 2.38776779 |
84 | Abnormal ciliary motility (HP:0012262) | 2.37524375 |
85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37252681 |
86 | Dicarboxylic aciduria (HP:0003215) | 2.37252681 |
87 | Abnormality of purine metabolism (HP:0004352) | 2.33304198 |
88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33268025 |
89 | Bronchitis (HP:0012387) | 2.31913040 |
90 | Hypoalphalipoproteinemia (HP:0003233) | 2.31699653 |
91 | Recurrent otitis media (HP:0000403) | 2.31669678 |
92 | Type II lissencephaly (HP:0007260) | 2.30273767 |
93 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.28563943 |
94 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.28490672 |
95 | IgM deficiency (HP:0002850) | 2.26434563 |
96 | Chronic sinusitis (HP:0011109) | 2.25618699 |
97 | Abnormal platelet function (HP:0011869) | 2.20982578 |
98 | Impaired platelet aggregation (HP:0003540) | 2.20982578 |
99 | Conjugated hyperbilirubinemia (HP:0002908) | 2.20319140 |
100 | Seborrheic dermatitis (HP:0001051) | 2.19699710 |
101 | Cholelithiasis (HP:0001081) | 2.18892947 |
102 | Gastrointestinal inflammation (HP:0004386) | 2.18831217 |
103 | Metabolic acidosis (HP:0001942) | 2.18782338 |
104 | Generalized aminoaciduria (HP:0002909) | 2.17806954 |
105 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17023202 |
106 | Obstructive lung disease (HP:0006536) | 2.17023202 |
107 | Abnormality of T cell number (HP:0011839) | 2.15549191 |
108 | Keratoconjunctivitis (HP:0001096) | 2.15329376 |
109 | Bile duct proliferation (HP:0001408) | 2.15290714 |
110 | Abnormal biliary tract physiology (HP:0012439) | 2.15290714 |
111 | Status epilepticus (HP:0002133) | 2.14626953 |
112 | Cerebral edema (HP:0002181) | 2.13893844 |
113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12054489 |
114 | Basal cell carcinoma (HP:0002671) | 2.11323869 |
115 | Vascular calcification (HP:0004934) | 2.10507528 |
116 | Thrombocytosis (HP:0001894) | 2.10325671 |
117 | Abnormal gallbladder morphology (HP:0012437) | 2.10074815 |
118 | Neonatal onset (HP:0003623) | 2.09058156 |
119 | Cerebellar dysplasia (HP:0007033) | 2.08422399 |
120 | Upper motor neuron abnormality (HP:0002127) | 2.08106240 |
121 | Inflammation of the large intestine (HP:0002037) | 2.07588920 |
122 | Increased IgM level (HP:0003496) | 2.06826987 |
123 | Global brain atrophy (HP:0002283) | 2.05844165 |
124 | Spontaneous abortion (HP:0005268) | 2.04804829 |
125 | Abnormality of macrophages (HP:0004311) | 2.03886616 |
126 | Hemorrhage of the eye (HP:0011885) | 2.03684268 |
127 | Poikilocytosis (HP:0004447) | 2.03472529 |
128 | Hypoglycemic seizures (HP:0002173) | 2.03006652 |
129 | Abnormality of the fingertips (HP:0001211) | 2.02734787 |
130 | Stomatitis (HP:0010280) | 2.00210569 |
131 | Abnormality of the lower motor neuron (HP:0002366) | 1.99573261 |
132 | Chronic hepatic failure (HP:0100626) | 1.98814228 |
133 | Pigmentary retinal degeneration (HP:0001146) | 1.98239192 |
134 | Epidermoid cyst (HP:0200040) | 1.97986144 |
135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97100222 |
136 | Pulmonary infiltrates (HP:0002113) | 1.96688925 |
137 | IgG deficiency (HP:0004315) | 1.95302922 |
138 | Cerebral palsy (HP:0100021) | 1.94521993 |
139 | Recurrent bronchitis (HP:0002837) | 1.93886432 |
140 | Elevated hepatic transaminases (HP:0002910) | 1.93699273 |
141 | Broad alveolar ridges (HP:0000187) | 1.92118561 |
142 | Verrucae (HP:0200043) | 1.92038510 |
143 | Papilloma (HP:0012740) | 1.92038510 |
144 | Spastic diplegia (HP:0001264) | 1.91312410 |
145 | Rhabdomyolysis (HP:0003201) | 1.90763977 |
146 | Abnormality of the peritoneum (HP:0002585) | 1.90588172 |
147 | Abnormality of T cell physiology (HP:0011840) | 1.90360101 |
148 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.89971859 |
149 | Gingival bleeding (HP:0000225) | 1.89943666 |
150 | Urticaria (HP:0001025) | 1.89267858 |
151 | Abnormality of the pleura (HP:0002103) | 1.87249916 |
152 | Asymmetric septal hypertrophy (HP:0001670) | 1.87066957 |
153 | Acute hepatic failure (HP:0006554) | 1.86366884 |
154 | Broad palm (HP:0001169) | 1.85601154 |
155 | Keratoconjunctivitis sicca (HP:0001097) | 1.84807567 |
156 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.84682894 |
157 | Abnormality of complement system (HP:0005339) | 1.83911056 |
158 | Deep palmar crease (HP:0006191) | 1.82070403 |
159 | Lethargy (HP:0001254) | 1.81450136 |
160 | Gastrointestinal stroma tumor (HP:0100723) | 1.80538461 |
161 | Exercise-induced muscle cramps (HP:0003710) | 1.80274819 |
162 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79757178 |
163 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79757178 |
164 | Recurrent sinusitis (HP:0011108) | 1.79263843 |
165 | Rhinitis (HP:0012384) | 1.79084837 |
166 | Pulmonary embolism (HP:0002204) | 1.78262267 |
167 | Recurrent viral infections (HP:0004429) | 1.78034852 |
168 | Epileptic encephalopathy (HP:0200134) | 1.77710769 |
169 | Atrioventricular block (HP:0001678) | 1.77556520 |
170 | Opisthotonus (HP:0002179) | 1.77432535 |
171 | Vomiting (HP:0002013) | 1.77421676 |
172 | Tubulointerstitial nephritis (HP:0001970) | 1.76663476 |
173 | Abnormality of reticulocytes (HP:0004312) | 1.75985141 |
174 | Nasal polyposis (HP:0100582) | 1.75762270 |
175 | Abnormality of serum amino acid levels (HP:0003112) | 1.75013855 |
176 | Chronic diarrhea (HP:0002028) | 1.74848864 |
177 | Progressive cerebellar ataxia (HP:0002073) | 1.74108177 |
178 | Cystic liver disease (HP:0006706) | 1.73987874 |
179 | Tented upper lip vermilion (HP:0010804) | 1.73846801 |
180 | Thrombophlebitis (HP:0004418) | 1.73739861 |
181 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73419339 |
182 | Steatorrhea (HP:0002570) | 1.73046552 |
183 | Albinism (HP:0001022) | 1.71000112 |
184 | Lissencephaly (HP:0001339) | 1.70746775 |
185 | Chronic bronchitis (HP:0004469) | 1.68673823 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PKN2 | 4.00317416 |
2 | BCKDK | 3.75685475 |
3 | MAP4K1 | 3.10841023 |
4 | SRPK1 | 3.09436831 |
5 | FLT3 | 2.80941697 |
6 | ERN1 | 2.77215241 |
7 | TXK | 2.53072618 |
8 | NEK1 | 2.35637392 |
9 | TYK2 | 2.28643811 |
10 | EEF2K | 2.28611252 |
11 | GRK6 | 2.25971782 |
12 | INSRR | 2.03841577 |
13 | FGFR4 | 2.02010661 |
14 | EPHA3 | 2.00647461 |
15 | WNK4 | 1.95429060 |
16 | MAP3K13 | 1.92294928 |
17 | FGFR2 | 1.79904109 |
18 | BRD4 | 1.72347461 |
19 | FGFR3 | 1.70788931 |
20 | TGFBR2 | 1.61840527 |
21 | CSF1R | 1.57397455 |
22 | TAOK3 | 1.54425307 |
23 | MAP3K7 | 1.50389573 |
24 | TYRO3 | 1.48583879 |
25 | TRIB3 | 1.46002921 |
26 | SIK1 | 1.44243556 |
27 | SIK3 | 1.42762689 |
28 | IRAK4 | 1.42376923 |
29 | MARK2 | 1.37270312 |
30 | MAP2K3 | 1.36399530 |
31 | KIT | 1.32482681 |
32 | IRAK3 | 1.32374479 |
33 | SIK2 | 1.32133241 |
34 | CDK19 | 1.30096575 |
35 | BLK | 1.29931799 |
36 | NTRK2 | 1.29554939 |
37 | BTK | 1.28433557 |
38 | PRPF4B | 1.26984990 |
39 | CDC42BPA | 1.25317065 |
40 | MAPK11 | 1.22858358 |
41 | CDK12 | 1.21419568 |
42 | IKBKE | 1.11375562 |
43 | MUSK | 1.10571703 |
44 | RIPK4 | 1.10140318 |
45 | EPHB1 | 1.10032650 |
46 | STK10 | 1.09099558 |
47 | SYK | 1.08971088 |
48 | NEK2 | 1.03351181 |
49 | MYLK | 1.01554139 |
50 | JAK1 | 1.00842851 |
51 | TEC | 1.00579160 |
52 | SGK3 | 1.00521216 |
53 | MAP3K10 | 0.99401383 |
54 | MAPK15 | 0.98787925 |
55 | MST1R | 0.98089606 |
56 | SGK223 | 0.97682648 |
57 | SGK494 | 0.97682648 |
58 | FES | 0.96991293 |
59 | CAMKK2 | 0.96721392 |
60 | WNK1 | 0.94420419 |
61 | TTN | 0.93941976 |
62 | RET | 0.91658441 |
63 | PDK1 | 0.91516983 |
64 | PDK4 | 0.90996055 |
65 | PDK3 | 0.90996055 |
66 | MAPK7 | 0.89830470 |
67 | TNIK | 0.89539448 |
68 | DYRK1B | 0.88225294 |
69 | TBK1 | 0.87317155 |
70 | MAP3K11 | 0.86484336 |
71 | ICK | 0.85673626 |
72 | HIPK2 | 0.83686124 |
73 | TNK2 | 0.80859001 |
74 | MAP2K2 | 0.80749252 |
75 | JAK2 | 0.77778881 |
76 | STK4 | 0.76888693 |
77 | PRKAA2 | 0.76797643 |
78 | CDK4 | 0.76346190 |
79 | LMTK2 | 0.75342521 |
80 | MAPK12 | 0.74731865 |
81 | PIK3CA | 0.72127801 |
82 | JAK3 | 0.71052347 |
83 | LRRK2 | 0.70443503 |
84 | ATR | 0.70282968 |
85 | FGR | 0.69584114 |
86 | CCNB1 | 0.67747038 |
87 | NLK | 0.67529334 |
88 | STK11 | 0.67201385 |
89 | MAP2K6 | 0.64143736 |
90 | CAMK4 | 0.64027874 |
91 | PIM1 | 0.63421901 |
92 | OBSCN | 0.63396840 |
93 | OXSR1 | 0.62792696 |
94 | RPS6KB2 | 0.62422114 |
95 | HCK | 0.61769733 |
96 | DAPK2 | 0.61719495 |
97 | ACVR1B | 0.61246434 |
98 | ITK | 0.60790930 |
99 | PRKCI | 0.60476724 |
100 | PRKD2 | 0.60415626 |
101 | LCK | 0.60156407 |
102 | GRK1 | 0.59782612 |
103 | RPS6KC1 | 0.59176216 |
104 | RPS6KL1 | 0.59176216 |
105 | PRKCZ | 0.58582886 |
106 | MAP3K1 | 0.57986000 |
107 | NEK6 | 0.57731467 |
108 | MATK | 0.56897810 |
109 | PRKCH | 0.56859975 |
110 | MAP2K4 | 0.55698797 |
111 | ZAP70 | 0.55605798 |
112 | RPS6KA6 | 0.55151150 |
113 | LYN | 0.54821204 |
114 | PINK1 | 0.54516928 |
115 | MTOR | 0.53973589 |
116 | FYN | 0.53759792 |
117 | CDC7 | 0.52488267 |
118 | DYRK1A | 0.50866772 |
119 | SGK2 | 0.50388632 |
120 | TRPM7 | 0.50109074 |
121 | DAPK1 | 0.49986120 |
122 | ERBB2 | 0.48411858 |
123 | MAP3K14 | 0.48271340 |
124 | TSSK6 | 0.47891788 |
125 | PDPK1 | 0.47094818 |
126 | CHUK | 0.45232005 |
127 | MARK3 | 0.44874298 |
128 | PDK2 | 0.44030721 |
129 | TGFBR1 | 0.43076428 |
130 | PASK | 0.41753926 |
131 | GRK7 | 0.41181321 |
132 | PRKCQ | 0.37453161 |
133 | CDK6 | 0.36880756 |
134 | PTK6 | 0.36730458 |
135 | CAMK1 | 0.36389790 |
136 | ARAF | 0.34742303 |
137 | ALK | 0.34149324 |
138 | CAMKK1 | 0.34121953 |
139 | AKT2 | 0.34003572 |
140 | RPS6KA2 | 0.32967573 |
141 | CSK | 0.32404874 |
142 | MAPK4 | 0.30641543 |
143 | PRKAA1 | 0.30295613 |
144 | IKBKB | 0.29918091 |
145 | PTK2B | 0.29444231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.62316167 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09187745 |
3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79562749 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.73174701 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.72740118 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.69875969 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.69705304 |
8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.66341796 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59176562 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58187938 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51525355 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50570994 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41271089 |
14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39385694 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33854517 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29942426 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.23885068 |
18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18124007 |
19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14833230 |
20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.14551224 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13710120 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.05908442 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.95079244 |
24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.91433969 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.89459154 |
26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86973953 |
27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.85004932 |
28 | Lysine degradation_Homo sapiens_hsa00310 | 1.84225822 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.78056925 |
30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77650337 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77615826 |
32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75560748 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73265448 |
34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70952443 |
35 | ABC transporters_Homo sapiens_hsa02010 | 1.70053245 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69926165 |
37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62633296 |
38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.62351411 |
39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60270341 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56242720 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55272967 |
42 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.55023886 |
43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53675316 |
44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51985083 |
45 | Asthma_Homo sapiens_hsa05310 | 1.49351926 |
46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47497998 |
47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46842268 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.44770840 |
49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44608037 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44448248 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42936070 |
52 | Bile secretion_Homo sapiens_hsa04976 | 1.42270690 |
53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38493616 |
54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38383602 |
55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36443263 |
56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33423961 |
57 | Measles_Homo sapiens_hsa05162 | 1.31664156 |
58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31651535 |
59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.29411367 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27518096 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26506709 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24012816 |
63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.23205847 |
64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22376770 |
65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22055394 |
66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17872613 |
67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17473324 |
68 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.17442121 |
69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.15960434 |
70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09149202 |
71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09022027 |
72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08911873 |
73 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07964297 |
74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05011539 |
75 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04932916 |
76 | Tuberculosis_Homo sapiens_hsa05152 | 1.04734542 |
77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04332802 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.03964085 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03261062 |
80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03009240 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01241333 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00844875 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98822809 |
84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96060085 |
85 | Phototransduction_Homo sapiens_hsa04744 | 0.95428705 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95134526 |
87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95118138 |
88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93344071 |
89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93243336 |
90 | Influenza A_Homo sapiens_hsa05164 | 0.91656017 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90519375 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86927304 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84616596 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82559766 |
95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80808149 |
96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78844596 |
97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78181958 |
98 | Hepatitis C_Homo sapiens_hsa05160 | 0.77556365 |
99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75185401 |
100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74827435 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72255350 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68894491 |
103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64966533 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63781335 |
105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63295540 |
106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62817361 |
107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62586544 |
108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61079174 |
109 | DNA replication_Homo sapiens_hsa03030 | 0.60261537 |
110 | Nicotine addiction_Homo sapiens_hsa05033 | 0.60042789 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58522892 |
112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57642550 |
113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57513035 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.57273045 |
115 | Morphine addiction_Homo sapiens_hsa05032 | 0.55143949 |
116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54801523 |
117 | Hepatitis B_Homo sapiens_hsa05161 | 0.54137889 |
118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53836144 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53532329 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52072515 |
121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51455310 |
122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51196725 |
123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50682138 |
124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49301324 |
125 | Base excision repair_Homo sapiens_hsa03410 | 0.49193971 |
126 | Endocytosis_Homo sapiens_hsa04144 | 0.48852859 |
127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47056740 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46324059 |
129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46227122 |
130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46088978 |
131 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44623722 |
132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40850082 |
133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40725822 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40444165 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39079744 |
136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38624124 |
137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36172087 |
138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35550465 |
139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35052239 |
140 | Platelet activation_Homo sapiens_hsa04611 | 0.34509861 |
141 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33578278 |
142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33136035 |
143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32795353 |
144 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30992829 |
145 | Insulin secretion_Homo sapiens_hsa04911 | 0.30922246 |
146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30030194 |
147 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29979425 |
148 | Apoptosis_Homo sapiens_hsa04210 | 0.29565049 |
149 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27762802 |
150 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27260871 |
151 | Mismatch repair_Homo sapiens_hsa03430 | 0.23054748 |
152 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13585755 |
153 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.12069074 |
154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10150624 |
155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.09833988 |
156 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08538610 |
157 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.08104273 |
158 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.07575997 |
159 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.07513291 |
160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07021177 |
161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06734103 |
162 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.05929654 |
163 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.05898092 |
164 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.03479732 |
165 | Purine metabolism_Homo sapiens_hsa00230 | 0.01810896 |
166 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.01596259 |
167 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0043685 |